Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Watson

Showing results (1121-1130 of 1,171) with videos related to

Pageof 118
Sort By:
Haematologica|July 21, 2018
Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VIPhillip L R Nicolson, Craig E Hughes, Stephanie Watson, et al.
Cardiovascular Research|April 17, 2018
Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillationAlessandra Borgognone, Eduard Shantsila, Sophie M Worrall, et al.
Molecular & Cellular Proteomics : MCP|December 26, 2006
A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6b-B, a novel immunoreceptor tyrosine-based inhibitory motif proteinYotis A Senis, Michael G Tomlinson, Angel García, et al.
Blood Advances|February 1, 2019
Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbαCaroline Kardeby, Knut Fälker, Elizabeth J Haining, et al.
Blood|May 22, 2010
JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemiaJuan Li, Dominik Spensberger, Jong Sook Ahn, et al.
Journal of Thrombosis and Haemostasis : JTH|November 5, 2019
Interspecies differences in protein expression do not impact the spatiotemporal regulation of glycoprotein VI mediated activationJoanne L Dunster, Amanda J Unsworth, Alexander P Bye, et al.
Blood|January 11, 2014
Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assayMarie Lordkipanidzé, Gillian C Lowe, Nicholas S Kirkby, et al.
Journal of Thrombosis and Haemostasis : JTH|August 4, 2023
Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapyFawaz O Alenazy, Maan H Harbi, Dean P Kavanagh, et al.
Communications Biology|April 7, 2023
Divalent nanobodies to platelet CLEC-2 can serve as agonists or antagonistsJoanne C Clark, Eleyna M Martin, Luis A Morán, et al.
Frontiers in Public Health|September 19, 2025
Supporting linkage facilitators working with persons with opioid use disorder: challenges, advances, and future directionsTess K Drazdowski, Anthony P Coetzer-Liversage, L A R Stein, et al.
Pageof 118

Showing results (1121-1130 of 1,171) with videos related to

Sort By:
Pageof 118
Haematologica|July 21, 2018
Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VIPhillip L R Nicolson, Craig E Hughes, Stephanie Watson, et al.
Cardiovascular Research|April 17, 2018
Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillationAlessandra Borgognone, Eduard Shantsila, Sophie M Worrall, et al.
Molecular & Cellular Proteomics : MCP|December 26, 2006
A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6b-B, a novel immunoreceptor tyrosine-based inhibitory motif proteinYotis A Senis, Michael G Tomlinson, Angel García, et al.
Blood Advances|February 1, 2019
Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbαCaroline Kardeby, Knut Fälker, Elizabeth J Haining, et al.
Blood|May 22, 2010
JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemiaJuan Li, Dominik Spensberger, Jong Sook Ahn, et al.
Journal of Thrombosis and Haemostasis : JTH|November 5, 2019
Interspecies differences in protein expression do not impact the spatiotemporal regulation of glycoprotein VI mediated activationJoanne L Dunster, Amanda J Unsworth, Alexander P Bye, et al.
Blood|January 11, 2014
Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assayMarie Lordkipanidzé, Gillian C Lowe, Nicholas S Kirkby, et al.
Journal of Thrombosis and Haemostasis : JTH|August 4, 2023
Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapyFawaz O Alenazy, Maan H Harbi, Dean P Kavanagh, et al.
Communications Biology|April 7, 2023
Divalent nanobodies to platelet CLEC-2 can serve as agonists or antagonistsJoanne C Clark, Eleyna M Martin, Luis A Morán, et al.
Frontiers in Public Health|September 19, 2025
Supporting linkage facilitators working with persons with opioid use disorder: challenges, advances, and future directionsTess K Drazdowski, Anthony P Coetzer-Liversage, L A R Stein, et al.
Pageof 118